Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserve
| Image |  |
|---|---|
| Description | scientific article published on 21 January 2020 |
| Author/s |
author: Margaret M Redfield James E Udelson |
| Publication date | January 21, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |